Leptin reduces ovariectomy-induced bone loss in rats

Endocrinology

Volumn 142, Issue 8, 2001, Pages 3546-3553

  Burguera, Bartolome ^a   Hofbauer, Lorenz C ^b   Thomas, Thierry ^c,d   Gori, Francesca ^c   Evans, Glenda L ^c   Khosla, Sundeep ^c   Riggs, B Lawrence ^c   Turner, Russell T ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c MAYO CLINIC   (United States)

^d UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECOMBINANT LEPTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE REMODELING; BONE TURNOVER; CONTROLLED STUDY; ESTROGEN THERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; TRABECULAR BONE;

EID: 0034914287     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.8.8346     Document Type: Article

References (53)

1. Medical progress series: Involutional osteoporosis
2. Bone mass and body composition in normal women
3. Epidemiology of vertebral fractures in women
4. Predictors of bone mass in perimenopausal women
5. Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density
6. Conversion of androstenedione to estrone by human tissue
7. Determinants of total body and regional bone mineral density in normal postmenopausal women
8. A multicenter study of the influence of fat and lean mass on bone mineral content: Evidence for differences in their relative influence at major fracture sites. Early Postmenopausal Intervention Cohort (EPIC) Study
9. Age-related changes in body composition of healthy and osteoporotic women
10. Influence of weight and gonadal status on total and regional bone mineral content and on weight-bearing and non weight-bearing bone, measured by dual-energy x-ray absorptiometry
11. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
12. Neuroendocrine regulation and actions of leptin
13. The leptin receptor
14. Localization of leptin receptor in human brain
15. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
16. Leptin modulates the T-cell immune response and reverses starvation-induced immunosupression
17. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma
18. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes
19. Interleukin-1β and tumor necrosis factor-α but not interleukin-6 stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
20. Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation
21. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
22. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
23. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
24. Leptin is a potent stimulator of bone growth in ob/ob mice
25. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice
26. Effects of the obese gene product on body weight regulation in ob/ob mice
27. Weight-reducing effects of the plasma protein encoded by the obese gene
28. Early onset of reproductive function in normal female mice treated with leptin
29. Leptin is not necessary for gestation and parturition but regulates maternal nutrition via a leptin resistance state
30. Estrogen does not increase bone formation in growing rats
31. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee
32. Multilineage potential of adult human mesenchymal stem cells
33. Vertebral post-menopausal bone loss is reduced in overweight women: A longitudinal study in 155 early postmenopausal women
34. Effects of weight and body mass index on bone mineral density in men and women: The Framingham Study
35. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects
36. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
37. Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women
38. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
39. Leptin induces mitogen-activated protein kinase-dependent proliferation of C3H10T1/2 cells
40. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated
41. Leptin inhibits osteoclast generation
42. Leptin levels vary significantly during the menstrual cycle, pregnancy, and in vitro fertilization treatment: Possible relation to estradiol
43. Serum leptin levels in normal children: Relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage
44. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans
45. Serum leptin in short children born small for gestational age: Relationship with the growth response to growth hormone treatment
46. The relationship between leptin concentration and bone metabolism in the human fetus
47. Obesity and the hypothalamus: Novel peptides for new pathways
48. Decreased cerebrospinalfluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
49. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans
50. Obesity is associated with a decreased of leptin transport across the blood brain barrier in rats
51. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea
52. Bone size and volumetric density in women with anorexia nervosa receiving estrogen replacement therapy and in women recovered from anorexia nervosa
53. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa